Prognostic relevance of urinary bladder cancer susceptibility loci

• Published in: PloS one 2014-02, Vol.9 (2), p.e89164-e89164
• Main Authors: Grotenhuis, Anne J, Dudek, Aleksandra M, Verhaegh, Gerald W, Witjes, J Alfred, Aben, Katja K, van der Marel, Saskia L, Vermeulen, Sita H, Kiemeney, Lambertus A
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Analysis; Biology; Bladder; Bladder cancer; Cancer; Cancer research; Colorectal cancer; Development and progression; Disease Progression; Disease susceptibility; Etiology; Female; Genes; Genetic Loci - genetics; Genetic Predisposition to Disease - genetics; Genetics; Genomes; Genomics; Health risk assessment; Humans; Invasiveness; Kaplan-Meier Estimate; Loci; Male; Medical prognosis; Medical treatment; Medicine; Metastases; Metastasis; Methyl isobutyl carbinol; Middle Aged; Muscles; Neoplasm Recurrence, Local - genetics; Neoplasm Recurrence, Local - pathology; Patients; Polymorphism, Single Nucleotide - genetics; Prognosis; Prostate cancer; Rank tests; Regression analysis; Retrospective Studies; Smoking; Statistical analysis; Studies; Surveys; Survival; Tumors; Urinary bladder; Urinary Bladder Neoplasms - genetics; Urinary Bladder Neoplasms - mortality; Urinary Bladder Neoplasms - pathology; Urogenital system; Urology
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0089164

In the last few years, susceptibility loci have been identified for urinary bladder cancer (UBC) through candidate-gene and genome-wide association studies. Prognostic relevance of most of these loci is yet unknown. In this study, we used data of the Nijmegen Bladder Cancer Study (NBCS) to perform a comprehensive evaluation of the prognostic relevance of all confirmed UBC susceptibility loci. Detailed clinical data concerning diagnosis, stage, treatment, and disease course of a population-based series of 1,602 UBC patients were collected retrospectively based on a medical file survey. Kaplan-Meier survival analyses and Cox proportional hazard regression were performed, and log-rank tests calculated, to evaluate the association between 12 confirmed UBC susceptibility variants and recurrence and progression in non-muscle invasive bladder cancer (NMIBC) patients. Among muscle-invasive or metastatic bladder cancer (MIBC) patients, association of these variants with overall survival was tested. Subgroup analyses by tumor aggressiveness and smoking status were performed in NMIBC patients. In the overall NMIBC group (n = 1,269), a statistically significant association between rs9642880 at 8q24 and risk of progression was observed (GT vs. TT: HR = 1.08 (95% CI: 0.76-1.54), GG vs. TT: HR = 1.81 (95% CI: 1.23-2.66), P for trend = 2.6 × 10(-3)). In subgroup analyses, several other variants showed suggestive, though non-significant, prognostic relevance for recurrence and progression in NMIBC and survival in MIBC. This study provides suggestive evidence that genetic loci involved in UBC etiology may influence disease prognosis. Elucidation of the causal variant(s) could further our understanding of the mechanism of disease, could point to new therapeutic targets, and might aid in improvement of prognostic tools.